Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.45 -0.11 (-0.81%) Market Cap: 42.99 Bil Enterprise Value: 70.33 Bil PE Ratio: 22.63 PB Ratio: 0.94 GF Score: 79/100

Takeda Pharmaceutical Co Ltd Plasma-Derived Therapies Business Investor Meeting Transcript

Oct 10, 2019 / 01:00AM GMT
Release Date Price: $17.08 (-0.52%)
Unidentified Company Representative;Julie Kim
Takeda Pharmaceutical Company Limited - President of Plasma-Derived Therapies Business

Good morning, ladies and gentlemen, and thank you very much for joining us despite this early hour in the morning. We have 1 hour today, but there is no presentation. This is basically a Q&A session. And we would like to respond to the questions from the audience.

I would like to introduce the participants from our side, PDT business unit President, Julie Kim. And she will answer the questions from the audience today. If you have a question, please raise your hand, and we will bring the microphone to you. Please make sure that you accept the microphone from mic runner and ask the question. Please state your name and affiliation before you state the question. Thank you.

Today, we have a simultaneous translation available. There should be a headset in front of you, channel 1 is English, channel 2 is Japanese. Questions can be accepted either in English or Japanese, either of the 2 languages.

Julie, the floor is yours.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot